Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Clasificación en acciones #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Precio por acción
$0.60736143
Capitalización bursátil
$58.28M
Cambio (1 día)
-1.04%
Cambio (1 año)
-21.09%
País
TW
Comercio Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Categoría

Historial del precio de la acción de Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
Precio más alto de cierre: $0.61 el 2026-08-01

Precio más bajo de cierre: $1.47 el 2023-04-01
Historial del precio de la acción de Gwo Xi Stem Cell Applied Technology Co. , Ltd desde 2023 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -11.38%
2025 1.08%
2024 -27.87%
2023 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$550.92 38.61%
US
$1.06K 59.05%
NL
$147.61 462.97%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH